Literature DB >> 26691422

Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation.

E Viner Smith1, A C Tierney1,2, D Klarica3, P Walker3, S Avery3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26691422     DOI： 10.1038/bmt.2015.312

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation.

Authors:  C Annaloro; P Usardi; L Airaghi; V Giunta; S Forti; A Orsatti; M Baldini; A Delle Volpe; G Lambertenghi Deliliers
Journal:  Bone Marrow Transplant       Date:  2008-01-14       Impact factor: 5.483

2.  The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up.

Authors:  Michael Jelinek; Margarite J Vale; Danny Liew; Leeanne Grigg; Anthony Dart; David L Hare; James D Best
Journal:  Heart Lung Circ       Date:  2009-08-03       Impact factor: 2.975

3.  Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.

Authors:  Eric J Chow; Beth A Mueller; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Paul J Martin; Debra L Friedman; Stephanie J Lee
Journal:  Ann Intern Med       Date:  2011-07-05       Impact factor: 25.391

4.  Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.

Authors:  Saro H Armenian; Can-Lan Sun; Tabitha Vase; Kirsten K Ness; Emily Blum; Liton Francisco; Kalyanasundaram Venkataraman; Raynald Samoa; F Lennie Wong; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

5.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Authors:  H B Rubins; S J Robins; D Collins; C L Fye; J W Anderson; M B Elam; F H Faas; E Linares; E J Schaefer; G Schectman; T J Wilt; J Wittes
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

Review 6.  Lifestyle modification for metabolic syndrome: a systematic review.

Authors:  Nikhil Bassi; Ilya Karagodin; Serena Wang; Patricia Vassallo; Aparna Priyanath; Elaine Massaro; Neil J Stone
Journal:  Am J Med       Date:  2014-07-05       Impact factor: 4.965

7.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

8.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.

Authors:  N S Majhail; M E Flowers; K K Ness; M Jagasia; P A Carpenter; M Arora; S Arai; L Johnston; P J Martin; K S Baker; S J Lee; L J Burns
Journal:  Bone Marrow Transplant       Date:  2008-08-25       Impact factor: 5.483

9.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

10.  Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.

Authors:  Rena R Wing; Wei Lang; Thomas A Wadden; Monika Safford; William C Knowler; Alain G Bertoni; James O Hill; Frederick L Brancati; Anne Peters; Lynne Wagenknecht
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112
View more
  2 in total

Review 1.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 2.  Type 2 Diabetes Mellitus, the Metabolic Syndrome, and Its Components in Adult Survivors of Acute Lymphoblastic Leukemia and Hematopoietic Stem Cell Transplantations.

Authors:  Bella Bielorai; Orit Pinhas-Hamiel
Journal:  Curr Diab Rep       Date:  2018-04-18       Impact factor: 4.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.